GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » ROE %

Shanghai INT Medical Instruments Co (HKSE:01501) ROE % : 11.99% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shanghai INT Medical Instruments Co's annualized net income for the quarter that ended in Jun. 2024 was HK$216.5 Mil. Shanghai INT Medical Instruments Co's average Total Stockholders Equity over the quarter that ended in Jun. 2024 was HK$1,805.5 Mil. Therefore, Shanghai INT Medical Instruments Co's annualized ROE % for the quarter that ended in Jun. 2024 was 11.99%.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's ROE % or its related term are showing as below:

HKSE:01501' s ROE % Range Over the Past 10 Years
Min: 8.66   Med: 11.62   Max: 23.23
Current: 11.21

During the past 9 years, Shanghai INT Medical Instruments Co's highest ROE % was 23.23%. The lowest was 8.66%. And the median was 11.62%.

HKSE:01501's ROE % is ranked better than
78.95% of 798 companies
in the Medical Devices & Instruments industry
Industry Median: 1.29 vs HKSE:01501: 11.21

Shanghai INT Medical Instruments Co ROE % Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co ROE % Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial Premium Member Only 9.92 10.75 8.66 9.80 11.08

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.74 10.39 9.48 11.99 10.54

Competitive Comparison of Shanghai INT Medical Instruments Co's ROE %

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's ROE % falls into.


;
;

Shanghai INT Medical Instruments Co ROE % Calculation

Shanghai INT Medical Instruments Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=171.129/( (1688.489+1803.905)/ 2 )
=171.129/1746.197
=9.80 %

Shanghai INT Medical Instruments Co's annualized ROE % for the quarter that ended in Jun. 2024 is calculated as

ROE %=Net Income (Q: Jun. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Jun. 2024 ))/ count )
=216.468/( (1803.905+1807.145)/ 2 )
=216.468/1805.525
=11.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2024) net income data. ROE % is displayed in the 30-year financial page.


Shanghai INT Medical Instruments Co  (HKSE:01501) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=216.468/1805.525
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(216.468 / 844.704)*(844.704 / 2168.1275)*(2168.1275 / 1805.525)
=Net Margin %*Asset Turnover*Equity Multiplier
=25.63 %*0.3896*1.2008
=ROA %*Equity Multiplier
=9.99 %*1.2008
=11.99 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=216.468/1805.525
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (216.468 / 238.452) * (238.452 / 204.538) * (204.538 / 844.704) * (844.704 / 2168.1275) * (2168.1275 / 1805.525)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9078 * 1.1658 * 24.21 % * 0.3896 * 1.2008
=11.99 %

Note: The net income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shanghai INT Medical Instruments Co ROE % Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention or implantation and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, The United States and Other countries and regions. The majority of revenue is from the Chinese Mainland.
Executives
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Kindly Enterprise Development Group Co., Ltd. 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines